| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.005 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.084 | 0.009 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.29 | 0.009 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.12 | 0.01 |